A study in the Journal of Gastroenterology and Hepatology found a modified colorectal cancer screening tool that included body mass index led to improved risk prediction for advanced neoplasia. Researchers based the tool on the Asia Pacific Colorectal Screening score. See the abstract here. See the review article in Physician’s Briefing here.
“Data on risk of dementia from PPIs conflicts with earlier publications”
An NIH-supported study of 10,486 patients found no link between proton pump inhibitor use and patient risks for mild cognitive impairment, Alzheimer’s disease and dementia, based on patient-reported data of PPI use. The data, reported in the Journal of the American Geriatrics Society, contradict findings of two other recent studies. “The current findings do not
A study in the Annals of Internal Medicine found that older black patients had a 31% higher risk of colorectal cancer than older white patients. Researchers noted greater racial and ethnic disparities for distal colon and rectal cancer than for proximal colon cancer. “Black persons have the highest incidence of and mortality rates from CRC
In an unprecedented move, the FDA today granted accelerated approval to the cancer drug pembrolizumab (Keytruda – Merck & Co) for treatment of any unresectable or metastatic solid tumors associated with the genetic abnormality known as microsatellite instability. It’s the first time the agency approved a cancer treatment or indication that is not for a tumor
A study published in Cancer examined if patient navigation impacted colonoscopy outcomes. Here’s what they found: 1. Patients in the navigated group were 11.2 times more likely to complete colonoscopy than control patients. 2. Navigated patients were 5.9 times more likely to have adequate bowel preparation. 3. Navigated patients also missed no appointments compared to
The rise in the number of deaths caused by hepatitis makes the disease a global health threat on the level of tuberculosis and HIV, according to a World Health Organization report. The data, presented at the International Liver Congress, showed a 22% increase in deaths resulting from chronic hepatitis B and C from 2000 to
There is an old saying that brains are baffled by the end product of a bull’s digestion. But a similar product, from carefully selected human donors, might reduce recurrent hepatic encephalopathy in liver disease patients and protect their brains, according to Jasmohan Bajaj, MD, of Virginia Commonwealth University in Richmond, Va. “This is the first
Researchers find doctors spent an average of 3.08 hours on direct patient care and 3.17 hours on the computer during any given workday. The time spent on the electronic record varied greatly between physicians. Despite this, the time doctors spent online has increased steadily over the years. Progress notes accounted for the largest chunk of
Are the Russians still getting to you? A recent report suggests a 320% increase in the number of health care providers affected by hacking incidents from 2015 to 2016. Researchers also found that HHS’ Office for Civil Rights received more than $23.5 million last year in settlements for HIPAA violations that occurred in 2012 and
Biomarkers of liver injury may persist after hepatitis C treatment
A biomarker of liver damage may persist after hepatitis C treatment: About one-third of patients who were successfully treated to eliminate the hepatitis C virus continued to exhibit liver inflammation, a German study showed. The findings include people who took direct-acting antiviral (DAA) drugs, the current preferred therapy for the virus. “This is the first
